Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanin-concentrating hormone receptor 1 (MCHR1) is a class A G protein-coupled receptor that binds melanin-concentrating hormone (MCH). It is involved in regulating feeding behavior, energy homeostasis, sleep-wake cycles, mood, and reproductive functions, making it a potential therapeutic target for obesity, sleep disorders, and psychiatric conditions. Antagonists are being explored for appetite suppression and mood disorder treatment.
Antagonists block the action of endogenous MCH at the MCHR1 receptor site; Agonists stimulate MCHR1
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanin-Concentrating Hormone Receptor 1 (MCHR1).